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SINTESIS, PENCIRIAN DAN KAJIAN STRUKTUR TERBITAN PIRIDIN 
BERKEPENTINGAN PERUBATAN 
ABSTRAK 
Dalam kajian ini, dua puluh garam 2-amino-5-metilpiridin dan 2-amino-4-
metilpirimidin dengan asid karboksilik aromatik dan alifatik asli telah dikaji 
menggunakan kaedah spektroskopik seperti: kristalografi sinar-X serbuk dan hablur 
tunggal, spektroskopi inframerah (IR) dan resonan magnet nuklear (NMR). Dalam 
semua sebatian, N yang diprotonkan dan kumpulan 2-amino kation terikat dengan 
ikatan hidrogen kepada atom O karboksilat anion melalui sepasang ikatan hydrogen 
N‒H···O dan N+‒H···O¯, membentuk motif gelang   
    .  Penghalusan struktur 
menunjukkan yang empat belas dari sebatian menghablur dalam kumpulan ruang 
monoklinik, empat dalam triklinik dan setiap satu dalam tetragonal dan ortorombik. 
Dalam kajian ini, pembentukan hablur ditunjukkan oleh persetujuan yang baik antara 
corak belauan serbuk sampel dan corak simulasi dari data belauan hablur tunggal dan 
kedua-duanya berbeza dari corak serbuk bahan awal. Dalam semua sebatian, ikatan 
kombinasi N—H dalam piridin dan pirimidin ditunjukkan oleh puncak yang 
berhubungan kepada frekuensi terikan 1877 sehingga 2044 cm
‒1
 dan ion karboksilat 
dicirikan oleh frekuensi terikan asimetrik dan simetrik dalam kawasan 1550‒1650 
dan sekitar 1400 cm
‒1
, setiap satunya. Pemindahan proton dan tulang belakang 
semua sebatian juga telah dianalisis menggunakan 
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SYNTHESIS, CHARACTERIZATION AND STRUCTURAL STUDIES OF 
MEDICINALLY IMPORTANT PYRIDINE DERIVATIVES 
6 ABSTRACT 
In this work, twenty novel salts of 2-amino-5-methylpyridine and 2-amino-4-
methylpyrimidine with aromatic and aliphatic carboxylic acids have been 
investigated using spectroscopic methods such as powder and single crystal X-ray 
crystallography, infrared (IR) and nuclear magnetic resonance (NMR) spectroscopy. 
In all the compounds, the protonated N atom and the 2-amino group of the cations 
are hydrogen bonded to the carboxylate O atoms of the anions via a pair of N‒H···O 
and N
+‒H···O¯ hydrogen bonds, forming an   
     ring motifs. The refinement of 
the structures indicates that fourteen of the compounds crystallized in the monoclinic 
space group, four in triclinic and one each in tetragonal and orthorhombic. In this 
research, the formation of the new crystal is shown by a good consistency between 
the powder diffraction pattern of the bulk samples and the simulated patterns 
obtained from single X-ray diffraction data and they were different from the powder 
pattern of the starting materials. In all the compounds, the combination bond of the 
N‒H in pyridine and pyrimidine was shown by the peaks related to stretching 
frequencies of 1877 to 2044 cm
‒1
 and the ion of carboxylate is characterized by 
asymmetrical and symmetrical stretching frequencies in the region of 1550‒1650 and 
about 1400 cm‾1, respectively. The proton transfer and the skeleton for all the 
compounds were also analyzed by 
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CHAPTER 1                                                                                       
INTRODUCTION 
1.1 Supramolecular Chemistry and Non-covalent Interactions 
The phrase supramolecular chemistry has been described by Jean-Marie Lehn who 
has won the Nobel Prize in the research of “the chemistry of the intermolecular bond 
and of the molecular assemblies” (Lehn, 1978). Noncovalent forces are the 
fundamental tool for both supramolecular chemistry and crystal engineering 
(Desiraju, 2002; Rao, 2001). Investigation about supramolecular chemistry was 
initially inspired by the tendency to understand the formation of electrical 
phenomena via potassium and sodium ion carried in the nervous system (Lehn, 
1988). In 1967, Pedersen constructed a seminal contribution to this interest area in 
his report that macrocyclic crown ethers are able to bind metal cations such as 
potassium. Besides the research done by Pedersen (1967), seminal contributions by 
Boenigk (1988) on spherands and Lehn (1988) on cryptands promoted the 
conception of self-assembly and molecular recognition as an area of scientific 
research. Modern-day supramolecular chemistry intersects with several 
interdisciplinary research fields that bridges other sciences like chemistry, biology, 
and physics (Steed and Atwood, 2009). In general, supramolecular chemistry refers 
to the branch of chemistry that deals with the design and fabrication of great and 
complex supermolecular assemblies by a series of non-covalent bonding events that 
include intermolecular interactions between the components (Dunitz, 1991). While 
molecules are made with covalent bonds, supramolecular compounds are made by 
joining molecules through intermolecular interactions. 
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The reactivity between molecules depends on the functional groups, such as 
carboxamide, phenol, amine, alcohol, aniline, aromatic, halogen and carboxylic acid. 
Therefore, recognition of the functional group gives information about interactions 
and productions of compounds in a specified category (Carey and Sundberg, 2007).  
However, in supramolecular system the behavior of a certain functional group is not 
simply extracted. For instance, carboxylic acids not only constitute expected dimer 
but also form hydrogen bonding catemer and hydrogen ring motifs (Figure 1.1).   
 
 
Figure  1.1  One functional group can form more than one synthon in crystal 
structures. Three familiar functional groups and their familiar 
synthons are shown (Tiekink et al., 2010). 
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In the solid state, differently assembled patterns of functional groups have been 
called supramolecular synthons (Steed and Atwood, 2009). Generally, the functional 
group of COOH is connected to the finite dimer synthon but sometimes infinite 
catemers are formed. 
1.2 Supramolecular Architectures 
In general, supramolecular chemistry is described by non-covalent interactions. Non-
covalent interactions indicate the energies that keep supramolecular system together. 
The term non-covalent includes an immense range of attractions and repulsions 
effects which are summarized in Table 1.1 (Steed et al., 2007). 
In the area of supramolecular chemistry, the controlled formation of atoms and 
molecules via reversible linkage like hydrogen bonding, Van der Waals forces, π‒π 
stacking and etc is delved, and many organized architectures have been made by 
using molecular building blocks (Lingenfelder et al., 2004). 
Organic crystal structures formed from acid-base compounds have received 
particular attention in the predictable formation of supramolecular architectures 
(Shan et al., 2003). Self-organization is one of the important methods to create one, 
two or three-dimensional networks through O—H···O, N—H···O and other weak 
intermolecular forces (Li et al., 2007).  Aromatic acids are important in crystal 
engineering because they can form directional and strong hydrogen bonds (Bhogala 
and Nangia, 2003), also the number and different location of the carboxylic groups in 
an aromatic ring can give rise to different types of hydrogen bond and architecture 
(Zhang and Chen, 2005). 
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Table  1.1  Summary of supramolecular interactions (Steed et al., 2007). 
Interaction Strength (kJ/mol) 
ion–ion 200 – 300 
Ion - dipole 50 – 200 
Dipole - dipole 5 – 50 
Hydrogen bonding 4 – 120 
Cation–π 5 – 80 
π–π 0 – 50 
Van der Waals ˂ 5 (kJ/mol) but variable        
depending on surface area 
 
 
Hydrophobic Related to solvent–solvent 
interaction energy 
                    
1.2.1  Hydrogen Bonding 
The hydrogen bonding was discovered about hundred years ago (Steiner, 2002), but 
still is a subject of very important scientific research. The hydrogen bond, due to 
high degree of directionality and strength is the most important non-covalent 
interaction. It states a particular type of dipole-dipole interaction between a donor 
(D) and an acceptor (A), via an intermediate atom of hydrogen (Vilar et al., 2004). In 
this process, the hydrogen atom is covalently bound with an extremely 
electronegative atom such as nitrogen (N), oxygen (O) or fluorine (F), as the donor. 
The electron density of the covalent bond is shifted to the donor atom; hence, a 
partial positive charge (net atomic charge) is created on the hydrogen atom. This 
charge interacts with the electron cloud around the acceptor (Torshin et al., 2002). 
Hydrogen bond is generally written as D‒H···A.  A typical hydrogen bond is shown 
in Figure 1.2.  
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Figure  1.2  A secondary amine donating hydrogen bond to a carbonyl acceptor, (b) 
the standard way to indicate acceptor and donor atoms (Steed and 
Atwood, 2009) 
There are also important hydrogen bond interactions connecting hydrogen atoms 
attached to carbon, instead of electronegative atoms such as nitrogen and oxygen 
(Jeffrey and Jeffrey, 1997). A bond between carbon and hydrogen is the carbon 
hydrogen bond (C‒H) that can be seen in many organic structures (March, 1992). 
The strength of hydrogen bonds is very different in various systems. It depends on 
the electronegativity of the donor atom and the geometry of hydrogen bond in the 
structure. Hydrogen bonds usually appear in a broad range of geometries, lengths and 
strengths that can be classified into three wide categories, Table 1.2 shows their 
properties.  
 
Table  1.2  Properties of hydrogen bonds (Steed et al., 2007). 
 Strong Moderate Weak 
Type of bonding Mostly covalent Mostly electrostatic Electrostatic 
H-bond ( ) 1.2‒1.5 1.5‒2.2 2.2‒3.2 
Bond angle ( ) 175‒180 130‒180 90‒150 
Bond energy (kJ/mol) 14‒40 4‒15 ˂ 4 
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The types of geometries of the hydrogen bondings are summarized in Figure 1.3. 
These geometries of hydrogen bond are called primary hydrogen bond interactions, 
because a direct interaction occurs between donor and acceptor group (Steed and 
Atwood, 2009). 
 
Figure  1.3  Different types of hydrogen bond geometries: (a) linear, (b) bent, (c) 
donating bifurcated, (d) accepting bifurcated, (e) trifurcated and (f) 
three center bifurcated (Steed et al., 2007). 
1.2.2 Graph Sets 
Etter (1985) presented a simple and general method for characterizing, comparing 
and recognizing patterns of hydrogen bonding in molecular aggregates. All types of 
hydrogen bonds have been defined just by four simple motifs. The aim of graph set 
designator is to describe the similarities and differences of hydrogen-bonded arrays 
(Etter, 1990). The process of specifying a graph set is determined by identifying the 
various types of hydrogen bonds present in a given network and the molecular 
structures of acceptors and donors (Chin et al., 1999). The pattern formed through 
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hydrogen-bonded set by only one type of hydrogen bond is called a motif (Etter et 
al., 1990). A motif has one of four designators based on if the hydrogen bonds are 
intramolecular or intermolecular. Intermolecular hydrogen bonds generate ring (R), 
chain (C) and dimer (D) motifs. A self (S) motif is formed from intramolecular 
hydrogen bond. The repeating motifs due to hydrogen-bonding is specified by the 
following symbolization (Blagden et al., 1998): 
  
     
Where, G represents the motifs that can be C, R or S, a and d are the numbers of 
acceptor and donors, respectively, and n is the number of atoms included within the 
motif. 
The subscript (d) and the superscript (a) can be dropped whilst both values are one.  
The method of assigning an eight-membered graph-set formed with carboxylic acids 
is illustrated in Figure 1.4.  Different types of motifs by their graph sets are shown in 
Figure 1.5 (Chin et al., 1999).            
 




Figure ‎1.5  Different types of motif and their graph sets (Whitesell, 1999) 
 
1.3 Crystal Growth 
There are many types of methods for crystallization such as slow evaporation, slow 
cooling, solvent diffusion, vapor diffusion and reactant diffusion. All the samples in 
this research were grown by slow evaporation method. 
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1.3.1 Slow Evaporation 
Evaporation is certainly one of the simplest techniques for crystallizing organic small 
molecule compounds. Choice of suitable solvent is important since it greatly affect 
the mechanism of crystal growth, because the solvent may be included into the 
crystal lattice while the crystal starts to form. The rate of crystal growth decreases by 
reducing the rate of solvent evaporation and cooling the solution. The solution should 
be kept by covering it. Purification of materials are necessary precondition for crystal 
growth, if there are impurities in the compound an oil is created in the bottom of the 
container (Holden and Morrison, 1982).  
1.4 Problem Statement 
Since the early twentieth century, pyridine derivatives have been commercially 
important. Pyridine derivatives have long been used in applications for medical 
drugs. In addition to bioactive ingredients, pyridines also have applications in 
polymers and dyes. In view of its medicinal importance, new compounds are needed 
to find more efficient source of medical drugs.  In this thesis, twenty novel 
compounds were characterized by IR and NMR spectroscopy methods and the 
crystal structures were analyzed by single crystal X-ray crystallography.  
Since many pharmaceuticals have carboxylic acid or pyridine functionalities, the 
proton transfer along hydrogen bonds between a carboxylic oxygen and a pyridine 
nitrogen atom has drawn considerable attention. Deprotonation of carboxylic acid 
renders it a better hydrogen bond acceptor, which in turn affects the molecular 
aggregation in crystals of salt. 
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1.5 Research Objectives 
The objectives of this study are: 
1. To synthesize new organic salts of 2-amino-5-methylpyridine and 2-
amino-4-methylpyrimidine with carboxylic acid derivatives. 
2. To characterize the organic salts by spectroscopy methods. 
3. To analyze the molecular and crystal structure of 2-amino-5-
methylpyridine and 2-amino-4-methylpyrimidine with carboxylic acid 
derivatives.  
4. To analyze the intermolecular and intramolecular interactions formed in 
the crystal structure of the organic salts.  
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2 CHAPTER 2                                                                                                    
LITERATURE REVIEW 
2.1  Hydrogen Bonding Interactions and Supramolecular Chemistry  
The interactions of hydrogen bond are the strongest of the non-covalent bond 
interactions and are directional. The study of bonds  between ions and molecules is 
one of the topics at the present time (Braga and Grepioni, 1999). Investigations of 
intermolecular and inter-ionic bonds have great relation for the basic sciences, but 
are also helpful in connection with practical applications. It is clear that the 
recognition and assembly processes lead to the superstructure from components 
through intermolecular interactions. Therefore, the desired comprehensive physical 
and chemical properties are resulted via a reasonable control of these processes 
(Kepert and Rosseinsky, 1999).   
Hydrogen bonding plays a fundamental role in biochemical process, catalytic, 
chemical, crystal engineering and supramolecular chemistry (Epstein and Shubina, 
2002). In recent years, different kinds of hydrogen bonds have been recognized, and 
all types of them have been widely investigated carefully to their structural (Suresh, 
2007) and spectral (Kruszynski, 2008) features. 
In crystal engineering, carboxylic acids demonstrate most common functional groups 
since they have an H-bond donor and acceptor with a structure that leads to self-
association via homosynthon motifs. In fact, self-association of carboxylic acids 
through centrosymmetric dimer or catemer motifs are well-known (Aitipamula and 
Nangia, 2005; Arora and Pedireddi, 2003). Furthermore, carboxylic acids are 
appropriate choices for multicomponent crystals because they produce stable 
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supramolecular heterosynthons with some different types of nitrogen-containing 
compounds. 
The crystal structure of 2-aminopyridine nicotinic acetic reported by Jebas et al. 
(2006) consists of one protonated 2-aminopyridinium cation and one nicotinic 
acetate anion in asymmetric unit (Figure 2.1). 
 
  Figure  2.1  An ORTEP diagram with the atom labeling scheme. Thermal ellipsoids 
shown at fifty percent probability. Dashed lines represent hydrogen 
bonds (Jebas et al., 2006). 
 
In the crystal packing (Figure 2.1), the protonated N3 atom and the 2-amino group 
(N2) are hydrogen-bonded to the carboxylate oxygen atoms (O1 and O2) via a pair 
of intermolecular N—H···O hydrogen bonds, creating an   
     ring motif 
(Bernstein et al., 1995).  
In protonation process from carboxyl group to the 2-aminopyridine molecule, the 
internal angle [C11—N3—C7] was widened compared to the corresponding angle in 
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non-protonated 2-aminopyridine. A considerable increase in the bond length of 
C11—N3 and decrease in the bond lengths of N2—C7 and N3—C7 in the protonated 
2-aminopyridine are observed compared to the non-protonated 2-aminopyridine, thus 
confirming the protonation of 2-aminopyridine at atom N3. The cation generates a 
pattern of fork-like hydrogen bonding with anions as depicted in Figure 2.2. 
 
Figure  2.2  Hydrogen bonding pattern, illustrating the fork-like pattern of 2-
aminopyridine nicotinic acetate (Jebas et al., 2006). 
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 Figure  2.3 The 2-amino-3-methylpyridinium and the ortho-phthalate with atom 
labels, displaying fifty percent probability ellipsoids level. Dashed 
lines display hydrogen bonds (Jin et al., 2001). 
In the asymmetric unit of 2-amino-3-methylpyridinium ortho-phthalate (Jin et al., 
2001; Figure 2.3), atoms N1, N3 and 2-amino groups (NH2) act as hydrogen bond 
donors to atoms O3, O4, O1 and O2. The orhto-phthalic molecule is linked to a pair 
of 2-amino-3-methylpyridine molecules by N—H···O intermolecular hydrogen 
bonds to produce two eight-membered rings, each of which has the graph-set motif 
of   
    . 
The angles of C—N—C in pyridine rings are really sensitive to protonation 
(Boenigk, 1988; Jin, 2000) and this angle in pyridinium cation is always expanded 
compared to the non-protonated pyridine ring. The expansion of (C19—N3—C15) 
and (C13—N1—C9) indicates the type of protonated pyridine. 
By studying the geometry of carboxylic group, the features of complex can be found. 
The average bond lengths of C‒O in carboxylic group which construct hydrogen 
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bonds are 1.32 Å for hydroxyl (C‒OH), and 1.21 (3) Å for the carbonyl bond. The 
average C‒O bond length in the anion of carboxylate is related as 1.25 Å. The bond 
lengths of [C1‒O1 = 1.266 Å], [C1‒O2 = 1.243 Å], [C8‒O3 = 1.243 Å] and [C8‒O4 
= 1.264 Å] confirm that proton transfer occurred from carboxylic groups to 2-amino-
3-methylpyridine.  
The two 2-amino-3-methylpyridinium reported by Jin et al. (2001)  cations arranged 
in such way feature the existence of π‒stacking interaction. It appears that the two 
ions with positive charge repulse each other due to electrostatic force. But, it has 
been proven that the atom of C (5) in 2-aminopyridine acts as an electron donator 
from different derivatives such as amino, imino, monocation and dication. In current 
structure, the atoms [N (3), N (4)] and [C (9), C (15)] are electron receiving centers 
and electron donating centers, respectively. The two 2-amino-3-methylpyridinium 
entities aligned with each other in a manner of electron receiving to donating center. 
This explanation is the definition of π‒π interaction (Muehldorf et al., 1988). 
He et al. (2010) reported that for 2-aminopyridinium and 1-phenylcyclopropane-1-
carboxylate (Figure 2.4), the synthon formed is one of the four types of different 
synthons (Figure 2.5) between 2-aminopyridine and carboxylic acid when they form 
molecular complexes proposed by Bis and Zaworotko, (2005). 
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Figure  2.4  The asymmetric unit of 2-aminopyridinium and 1-phenylcyclopropane-                
1-carboxylate, with fifty percent probability ellipsoids level and atoms 
label for non-hydrogen atoms (He et al., 2010). 
 
Figure  2.5  Examples of supramolecular homo and hetero synthons: A carboxylic 
acid homosynthon I, a 2-aminopyridine homosynthon II, 2-
aminopyridine-carboxylic acid supramolecular heterosynthon III, and 2-
aminopyridinium-carboxylate supramolecular heterosynthon IV (Bis 
and Zaworotko, 2005). 
 
The 2-aminopyridinium cation and 1-phenylcyclopropane-1-carboxylate anion are 
linked through two N—H···O hydrogen bonds, forming type IV heterosynthon. 
These synthons are centrosymmetrically connected to generate a four-component 
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supramolecular via N—H···O hydrogen bond (Figure 2.6). The array unit is further 
sustained through C2—H2···π interaction [C2···Cg1 = 3.5465 (15) Å], where Cg1 is 
the centroid of 1-phenylcyclopropane-1-carboxylate anion (C10—C15) ring (Figure 
2.6). The crystal structure is also stabilized by C11—H11···O1 (‒x+1, ‒y+1, ‒z+1) 
and C12—H12···O1 (x+1, y, z) hydrogen bonds. 
 
 
Figure  2.6  A four-component supramolecular (DDAA array) unit that illustrates of 
type IV heterosynthon and a C—H···π interaction in the crystal packing 
(He et al., 2010) 
 
2-Aminopyrimidin-1-ium trichloroacetate reported by Hu et al. (2002) consists of 
one 2-aminopyrimidinium cation and one -1-ium trichloacetate anion in asymmetric 
unit (Figure 2.7). In the crystal packing the protonated N atom and the amino group 
(NH2) form hydrogen bonds with oxygen atoms of the carboxlate group [N
+—H···O‾ 
and N—H···O], generating an   
     ring motif (Figure 2.7).  
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Figure  2.7 The molecular configuration and atom-numbering scheme 2-
aminopyrimidin-1-ium trichloroacetate, showing fifty percent 
probability ellipsoids (Hu, 2002). 
 
Figure  2.8  Hydrogen bonding interactions in the title salt (Hu, 2002). 
Four possible motifs of 2-amino-4-methylpyrimidinium carboxylates (Figure 2.9) are 
reported by Aakerӧy et al. (2003). In the crystal structure, the ion-pairs are connected 
by an N—H···O hydrogen bond, substantially weaker, to create an infinite helical 
chain along [0 1 0] direction (Figure 2.10). The crystal structure of 2-
aminopyrimidinium and one -1-ium trichloacetate displays motif III.  
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Figure  2.9  Four possible configurations for adjacent ion-pairs of 2-amino-4-




Figure  2.10  Part of the crystal structure, indicating a helical chain along the b-axis. 
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2.2 Study of Powder X-ray Diffraction (PXRD) 
Adalder et al. (2012) reported four new co-crystals of pyrazinecarboxamide, with 
different types of monocarboxylic acids. The compounds are pyrazinecarboxamide - 
vanilic acid (PZA-VA), pyrazinecarboxamide-gallic acid (PZA-GA), 
pyrazinecarboxamide-1-hydroxy-2-naphthoic acid (PZA-1HNA) and 
pyrazinecarboxamide-indole-2-carboxylic acid (PZA-12CA). One of the 
characterization methods used was powder X-ray diffraction technique. Figure 2.11 
illustrates that the diffractogram of product solids (bulk) and the diffractogram 
obtained from single crystal X‒ray diffraction (SXRD) are similar to each other but 
are different from the diffraction pattern of the ingredient components. 
 
 
Figure  2.11  PXRD peaks of product and ingredient materials confirm a new phase 
(Adalder et al., 2012). 
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Four novel salts of 2-amino-4-methylpyridine, with different types of 
monocarboxylic acid were reported by Khalib et al. (2014). The reported compounds 
of 2-amino-4-methylpyridine 2-chlorobenzoic acid (2A4MP-2CBA), 2-amino-4-
methylpyridine 2-chlorobenzoic acid (2A4MP-4CBA), 2-amino-4-methylpyridine 3-
methylbenzoic acid (2A4MP-3MBA) and 2-amino-4-methylpyridine 4-
methylbenzoic acid (2A4MP-4MBA) were also characterized by powder diffraction 
technique apart from other characterization technique. The experimental 
diffractogram of product solids (bulk) and the calculated diffractogram (calculated 
from SXRD) are similar to each other and they are different from the PXRD 





Figure  2.12  The experimental and calculated (obtained from SXRD) PXRD patterns 
of (2A4MP-2CBA), (2A4MP-4CBA), (2A4MP-3MBA), (2A4MP-
4MBA) and their starting materials PXRD patterns (Khalib et al., 
2014). 
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2.3 Infrared Spectroscopy (IR) 
Five organic salt compounds assembled from 2-aminoheterocyclic and carboxylic 
acid derivatives (Figure 2.13), were reported by Jin et al. (2011)   
 




Jin et al. (2011) reported that peaks attributed to the asymmetrical and symmetrical 
stretching frequencies of carboxylate ion (‒COO‾) were found in the spectrum of the 
five salts. The results clearly feature that the 5, 7-dimethyl-1, 8-naphthyridine-2-
amine and 4-phenylthiazol-2-amine were protonated by corresponding carboxylic 
acids. 
Jin et al. (2014) have reported two organic salts assembled from banzylamine and 
carboxylic acid derivatives (Figure 2.14). The compounds are (benzylamine): (3,5-
dinitrobenzoic acid) [(HL
+





2-∙H2O] (II) (Figure 2.15). 
 
Figure  2.14  Structure of hydrogen bond synthons (Jin et al., 2014). 
  
In this report by Jin et al. (2014), peaks attributed to the asymmetrical and 
symmetrical stretching frequencies of carboxylate ion (‒COO‾) are also found in the 
two salts. These results also clearly show that the banzylamine was protonated by 3, 
5‒dinitrobenzoic and oxalic acids. 
